Philip Starkey Lewis

1.2k total citations · 1 hit paper
13 papers, 740 citations indexed

About

Philip Starkey Lewis is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Philip Starkey Lewis has authored 13 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in Philip Starkey Lewis's work include MicroRNA in disease regulation (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Extracellular vesicles in disease (3 papers). Philip Starkey Lewis is often cited by papers focused on MicroRNA in disease regulation (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Extracellular vesicles in disease (3 papers). Philip Starkey Lewis collaborates with scholars based in United Kingdom, Switzerland and Sweden. Philip Starkey Lewis's co-authors include Christopher E. Goldring, James W. Dear, Daniel J. Antoine, Jonathan G. Moggs, Kevin B. Park, Vivien Platt, D. Nicholas Bateman, David J. Webb, J. Terrence Coyle and Alasdair Gray and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Philip Starkey Lewis

13 papers receiving 726 citations

Hit Papers

Mechanistic Biomarkers Provide Early and Sensitive Detect... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to Hospital
    2013 328 citations Daniel J. Antoine, James W. Dear et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Starkey Lewis United Kingdom 10 293 195 188 178 140 13 740
Vivien Platt United Kingdom 5 355 1.2× 316 1.6× 221 1.2× 216 1.2× 300 2.1× 9 840
Joanna I. Clarke United Kingdom 6 203 0.7× 129 0.7× 134 0.7× 132 0.7× 82 0.6× 9 482
Xiaoling Wang China 18 102 0.3× 407 2.1× 126 0.7× 71 0.4× 72 0.5× 42 883
Kyle L. Poulsen United States 16 88 0.3× 257 1.3× 457 2.4× 169 0.9× 63 0.5× 29 878
Jin Chai China 18 126 0.4× 281 1.4× 362 1.9× 265 1.5× 79 0.6× 62 976
E. Alt United States 11 101 0.3× 235 1.2× 220 1.2× 135 0.8× 77 0.6× 24 810
Karim Hamesch Germany 8 130 0.4× 171 0.9× 245 1.3× 228 1.3× 56 0.4× 26 661
Julio Dávila Spain 12 216 0.7× 185 0.9× 54 0.3× 130 0.7× 20 0.1× 33 759
Emily O’Neill United States 7 115 0.4× 145 0.7× 158 0.8× 114 0.6× 34 0.2× 13 624
Eben S. Fox United States 19 96 0.3× 252 1.3× 224 1.2× 186 1.0× 58 0.4× 27 995

Countries citing papers authored by Philip Starkey Lewis

Since Specialization
Citations

This map shows the geographic impact of Philip Starkey Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Starkey Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Starkey Lewis more than expected).

Fields of papers citing papers by Philip Starkey Lewis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Starkey Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Starkey Lewis. The network helps show where Philip Starkey Lewis may publish in the future.

Co-authorship network of co-authors of Philip Starkey Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Starkey Lewis. A scholar is included among the top collaborators of Philip Starkey Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Starkey Lewis. Philip Starkey Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Forbes, Shareen, Andrew Bond, Paul S. Burgoyne, et al.. (2020). Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization. Science Translational Medicine. 12(526). 42 indexed citations
2.
Lewis, Philip Starkey, Lara Campana, Niya Aleksieva, et al.. (2020). Alternatively activated macrophages promote resolution of necrosis following acute liver injury. Journal of Hepatology. 73(2). 349–360. 126 indexed citations
3.
Morrison, Emma, Philip Starkey Lewis, Iqbal Toor, et al.. (2020). Transfer of hepatocellular microRNA regulates cytochrome P450 2E1 in renal tubular cells. EBioMedicine. 62. 103092–103092. 14 indexed citations
4.
Alwahsh, Salamah Mohammad, Benjamin J. Dwyer, Shareen Forbes, et al.. (2017). Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome. International Journal of Molecular Sciences. 18(2). 285–285. 40 indexed citations
5.
Thulin, Petra, Mariona Aulí, Gunnar Nordahl, et al.. (2016). A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat. Biomarkers. 22(5). 461–469. 26 indexed citations
6.
Walsh, Joanne, Laura E. Randle, Ina Schuppe‐Koistinen, et al.. (2015). Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome. Scientific Reports. 5(1). 16423–16423. 25 indexed citations
7.
Vliegenthart, A. D. Bastiaan, Philip Starkey Lewis, Carl S. Tucker, et al.. (2014). Retro-Orbital Blood Acquisition Facilitates Circulating microRNA Measurement in Zebrafish with Paracetamol Hepatotoxicity. Zebrafish. 11(3). 219–226. 25 indexed citations
8.
Lewis, Philip Starkey, et al.. (2014). MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans. Expert Review of Clinical Pharmacology. 7(3). 349–362. 43 indexed citations
9.
Antoine, Daniel J., James W. Dear, Philip Starkey Lewis, et al.. (2013). Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to Hospital. Hepatology. 58(2). 777–787. 328 indexed citations breakdown →
10.
Lewis, Philip Starkey, James W. Dear, Vivien Platt, et al.. (2011). Identification of endogenous normalizers for serum MicroRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer. Hepatology. 55(5). 1642–1643. 2 indexed citations
11.
Lewis, Philip Starkey, R. Chris Miall, Piotr Złomańczuk, et al.. (2000). Interval timing does not rely upon the circadian pacemaker. European Journal of Neuroscience. 12. 422–422. 2 indexed citations
12.
Gordon, Dan, Ian M. Baird, Rabih O. Darouiche, et al.. (1997). Liposomal nystatin (LNY) vs. amphotericin B (AMB) for Candidemia in non-neutropenic patients: A historical comparison. Clinical Infectious Diseases. 25(2). 382. 2 indexed citations
13.
Lewis, Philip Starkey, Jean–Jacques Garaud, & Francesca Parenti. (1988). A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria. Journal of Antimicrobial Chemotherapy. 21(suppl A). 61–67. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivien Platt Breakdown of academic impact, for papers by Joanna I. Clarke Breakdown of academic impact, for papers by Xiaoling Wang Breakdown of academic impact, for papers by Kyle L. Poulsen Breakdown of academic impact, for papers by Jin Chai Breakdown of academic impact, for papers by E. Alt Breakdown of academic impact, for papers by Karim Hamesch Breakdown of academic impact, for papers by Julio Dávila Breakdown of academic impact, for papers by Emily O’Neill Breakdown of academic impact, for papers by Eben S. Fox
Rankless by CCL
2026